ERCC6L2 and myelodysplastic syndrome: Several patients with acute erythroid leukemia have been reported, either progressing from MDS or as isolated disease, leading to the assumption that this AML subtype seems to be much more prevalent in ERCC6L2 germline-mutated patients (Table 1) (28).